Form 8-K - Current report:
SEC Accession No. 0001193125-24-195400
Filing Date
2024-08-07
Accepted
2024-08-07 07:06:32
Documents
15
Period of Report
2024-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d813823d8k.htm   iXBRL 8-K 24217
2 EX-99.1 d813823dex991.htm EX-99.1 67275
6 GRAPHIC g813823g30j89.jpg GRAPHIC 4171
  Complete submission text file 0001193125-24-195400.txt   234995

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mdgl-20240807.xsd EX-101.SCH 2871
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdgl-20240807_lab.xml EX-101.LAB 18757
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdgl-20240807_pre.xml EX-101.PRE 11724
17 EXTRACTED XBRL INSTANCE DOCUMENT d813823d8k_htm.xml XML 3802
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 241181392
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)